The community pharmacist's role in cancer screening and prevention

被引:14
作者
Havlicek, Anthony James [1 ]
Mansell, Holly [1 ]
机构
[1] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
D O I
10.1177/1715163516660574
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
As the Canadian population continues to age, the incidence of cancer is on the rise. To help alleviate the burden malignancy imposes on our health care system, a shift toward early cancer detection is necessary. Pharmacists are well positioned and willing to assume a more active role in cancer surveillance. Patients are receptive to pharmacist involvement and seem to prefer a convenient community pharmacy-based location for screening programs. The community pharmacist's current and potential role in cancer screening and prevention is summarized in this article. A review of screening recommendations and a discussion of opportunities will hopefully inspire pharmacists to consider incorporating malignancy screening initiatives into their practice.
引用
收藏
页码:274 / 282
页数:9
相关论文
共 39 条
[1]   Community pharmacist targeted screening for chronic kidney disease [J].
Al Hamarneh, Yazid N. ;
Hemmelgarn, Brenda ;
Curtis, Craig ;
Balint, Carlee ;
Jones, Charlotte A. ;
Tsuyuki, Ross T. .
CANADIAN PHARMACISTS JOURNAL, 2016, 149 (01) :13-17
[2]  
Ayorinde Abimbola Adebukola, 2013, Int J Pharm Pract, V21, P349, DOI 10.1111/ijpp.12041
[3]  
BC Cancer Agency, 2016, MEL
[4]   Recommendations on screening for prostate cancer with the prostate-specific antigen test [J].
Bell, Neil ;
Gorber, Sarah Connor ;
Shane, Amanda ;
Joffres, Michel ;
Singh, Harminder ;
Dickinson, James ;
Shaw, Elizabeth ;
Dunfield, Lesley ;
Tonelli, Marcello .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (16) :1225-1234
[5]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[6]  
Canadian Cancer Society, 2016, RISK FACT COL CANC
[7]  
Canadian Cancer Society, 2016, RISK FACT MEL
[8]  
Canadian Cancer Society, 2016, RISK FACT CERV CANC
[9]  
Canadian Cancer Society, 2016, RISK FACT LUNG CANC
[10]  
Canadian Cancer Society, 2016, RISK FACT BREAST CAN